The IPO is now effective; expect pricing and first trading day within 1-2 days. Monitor for the final pricing announcement and initial trading performance. The upcoming PDUFA date in February 2027 is the next major catalyst.
Price Chart
Executive Summary
The SEC declared effective Apnimed's S-1 registration statement for its IPO on July 30, 2026. The company is offering 10,000,000 shares at $14-$16 per share, with expected net proceeds of ~$134.6M to fund regulatory approval and commercialization of its lead candidate Oxnimbi (AD109) for obstructive sleep apnea, ahead of a PDUFA date of February 28, 2027.
Key Facts
- IPO declared effective on July 30, 2026 (SEC file number 333-297377).
- Offering 10,000,000 shares of common stock at $14-$16 per share.
- Expected net proceeds of approximately $134.6 million at midpoint.
- Lead drug candidate Oxnimbi (AD109) has a PDUFA date of February 28, 2027.
- Proceeds expected to fund operations through June 2028, addressing prior going concern uncertainty.
Financial Impact
IPO proceeds of ~$134.6 million (midpoint) will be used primarily for regulatory approval and commercialization of Oxnimbi.
Risk Factors
- Pre-revenue clinical-stage company with history of operating losses.
- FDA approval of Oxnimbi is not guaranteed; negative PDUFA outcome would severely impact valuation.
- Dilution from the IPO may pressure near-term stock price.
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002498 |
| Document: 9999999995-26-002498-index.html | 9999999995-26-002498 |
| Document: 9999999995-26-002498.txt | 9999999995-26-002498 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 5, 2026 11w ago | Insider Cluster | $27.88 $27.81 | ▼ −0.25% | ▼ −0.85% | $19.49 (−30.09%) |
Aug 3, 2026 12w ago | Insider Buy | $25.71 $26.85 | ▲ +4.43% | ▲ +5.67% | $19.49 (−24.19%) |
Jul 31, 2026 12w ago | 424B4 | $25.00 $26.25 | ▲ +5.00% | ▲ +3.76% | $19.49 (−22.04%) |
Jul 31, 2026 12w ago | EFFECT | $25.00 $29.71 | ▲ +18.84% | ▲ +15.85% | $19.49 (−22.04%) |
Jul 30, 2026 12w ago | 3 | $25.00 $29.71 | ▲ +18.84% | ▲ +15.85% | $19.49 (−22.04%) |
Jul 27, 2026 13w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers